June 23, 2026
Press Release
Vividion Therapeutics Doses First Patient in Phase Ib Combination Study of WRN Inhibitor VVD-214 in Patients with Advanced Colorectal Cancer
January 6, 2026
Publications & Posters
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High Cancers
January 6, 2026
Press Release
Vividion Publishes Discovery of WRN Inhibitor VVD-214 in Journal of Medicinal Chemistry
December 22, 2025
Press Release
Vividion Publishes Discovery of First-in-Class KEAP1 Activator, Supporting Ongoing Clinical Program in Oncology
December 22, 2025
Publications & Posters
A covalent allosteric molecular glue suppresses NRF2-dependent cancer growth
